Cases started on MDR-TB treatment in Nepal
Nepal: Cases started on MDR-TB treatment was 633 in 2024. ▲ Rising
Cases started on MDR-TB treatment in Nepal, 2008–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for cases started on mdr-tb treatment in Nepal is 633, measured in 2024.
Compared with earlier readings it is up 15.9% on the previous year and up 81.4% over ten years.
Over the whole period, cases started on mdr-tb treatment in Nepal peaked at 681 in 2022 and was at its lowest, 49, in 2008.
Nepal ranks 26th of 193 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 17 years of available data.
Cases started on MDR-TB treatment in Nepal, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 49 | — |
| 2009 | 156 | +218.4% |
| 2010 | 229 | +46.8% |
| 2011 | 213 | -7.0% |
| 2012 | 251 | +17.8% |
| 2013 | 388 | +54.6% |
| 2014 | 349 | -10.1% |
| 2015 | 379 | +8.6% |
| 2016 | 386 | +1.8% |
| 2017 | 429 | +11.1% |
| 2018 | 400 | -6.8% |
| 2019 | 378 | -5.5% |
| 2020 | 384 | +1.6% |
| 2021 | 418 | +8.9% |
| 2022 | 681 | +62.9% |
| 2023 | 546 | -19.8% |
| 2024 | 633 | +15.9% |
Nepal compared with similar countries
- Nepal's 633 is above the median for lower middle income countries, which is 120, 5.3× the median. (47 countries reporting)
- Nepal's 633 is above the median for South Asia, which is 352, 1.8× the median. (6 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in Nepal changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +218.4% | 49 | 156 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 102.5 | 49 | 156 | 2 |
| 2010s | 340.2 | 213 | 429 | 10 |
| 2020s | 532.4 | 384 | 681 | 5 |
Countries ranked near Nepal
- 23 Uganda 815 compare
- 24 Papua New Guinea 747 compare
- 25 Kyrgyzstan 725 compare
- 27 Turkmenistan 627 compare
- 28 Belarus 520 compare
- 29 Cote d'Ivoire 465 compare
More health data for Nepal
- Un projection of annual infant deaths, annual growth rate -1.95 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8518 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,326 deaths per 1,000 people (2090)
- Number of infants who die before age 1 955 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate -1.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0451 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in Nepal?
- Cases started on mdr-tb treatment in Nepal was 633 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in Nepal?
- The highest recorded value was 681 in 2022.
- What is the lowest cases started on mdr-tb treatment recorded in Nepal?
- The lowest recorded value was 49 in 2008.
- How does Nepal rank for cases started on mdr-tb treatment?
- Nepal ranks 26th out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in Nepal?
- Over the last ten years it is up 81.4%. The long-run trend across the full record is rising.
- Where does this Nepal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).